Since CXCL8 and SLC16A9 have been shown as a potential and novel therapeutic target with high diagnostic power common to UC and CRC, their expression level in CRC (n = 10), UC (n = 10) and adjacent normal tissues (n = 10) was checked by using RT-qPCR. The gene discussed is SLC16A9; the disease is colorectal carcinoma.